Breaking News
Get 40% Off 0
🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For Free Copy Portfolio
Close

Vivos Inc (RDGL)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.1745 +0.0050    +2.95%
15:59:00 - Closed. Currency in USD ( Disclaimer )
After Hours
0.1688
-0.0057
-3.2665%
15:59:56 - Delayed Data
Type:  Equity
Market:  United States
  • Volume: 812,283
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.1608 - 0.1778
Vivos 0.1745 +0.0050 +2.95%

RDGL Recent Sentiments

 
This page contains information on users’ sentiments for the Vivos Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
May 20, 2024 תמר רונן   0.1690 May 20, 2024 @ 0.1805 +6.80%
Mar 01, 2022 Steven Re   0.0688 Mar 25, 2022 @ 0.0640 -6.98%
Nov 24, 2021 alexis cruz   0.0900 Dec 17, 2021 @ 0.0787 -12.56%
Sep 23, 2021 Steven Re   0.1204 Oct 15, 2021 @ 0.1055 -12.38%
Jul 19, 2021 Donald Wilson   0.1090 Aug 13, 2021 @ 0.1045 -4.13%
Feb 08, 2021 Kai Nrp   0.0850 Mar 05, 2021 @ 0.0989 +16.35%
Feb 02, 2021 Tó Kaetano Caetano   0.0700 Feb 26, 2021 @ 0.0975 +39.29%
Jan 20, 2021 Dookie Monk   0.0880 Jan 24, 2021 @ 0.0920 +4.55%
Jan 14, 2021 Kathy Bagnell   0.2475 Feb 05, 2021 @ 0.0790 -68.08%
Jan 14, 2021 Sohit Scolia   0.2461 Feb 05, 2021 @ 0.0790 -67.90%
Jan 14, 2021 GAIL TIKKANEN   0.2750 Feb 05, 2021 @ 0.0790 -71.27%
Jan 07, 2021 Kai Nrp   0.1721 Jan 29, 2021 @ 0.0750 -56.42%
Jan 06, 2021 András Gyurasics   0.1800 Jan 29, 2021 @ 0.0750 -58.33%
Jan 04, 2021 aaa aaa   0.1300 Jan 29, 2021 @ 0.0750 -42.31%
Dec 11, 2020 Kathy Bagnell   0.2050 Jan 01, 2021 @ 0.1055 -48.54%
Dec 08, 2020 Emil Miclea   0.1714 Jan 01, 2021 @ 0.1055 -38.45%
Nov 20, 2020 mohamed mohsen   0.0262 Nov 20, 2020 @ 0.0250 -4.58%
Nov 20, 2020 Dakota Love   0.0250 Dec 11, 2020 @ 0.2000 +700.00%
Sep 28, 2020 Dakota Love   0.0261 Oct 23, 2020 @ 0.0265 +1.53%
Aug 27, 2020 Dakota Love   0.0309 Sep 18, 2020 @ 0.0275 -11.00%
Jun 25, 2020 Victor Guardia   0.0479 Jul 17, 2020 @ 0.0290 -39.46%
Nov 21, 2019 Serdar Erdogmus   0.0373 Dec 13, 2019 @ 0.0415 -11.26%
Oct 16, 2019 Wilberto Irizarry   0.0416 Nov 08, 2019 @ 0.0375 -9.86%
Sep 20, 2019 Wilberto Irizarry   0.0449 Oct 11, 2019 @ 0.0386 -14.03%
Aug 20, 2019 Kathy Bagnell   0.0400 Sep 13, 2019 @ 0.0480 -20.00%
Jul 16, 2019 Nolan Benedetti   0.0750 Aug 09, 2019 @ 0.0447 -40.40%
Jun 12, 2019 Dorien Vermeulen   0.0200 Jul 05, 2019 @ 0.0295 -47.50%
Jun 04, 2019 Kathy Bagnell   0.0031 Jun 28, 2019 @ 0.0038 -22.58%
Feb 27, 2019 Kathy Bagnell   0.0029 Mar 22, 2019 @ 0.0029 0.00%
Jan 08, 2019 Kathy Bagnell   0.0061 Feb 08, 2019 @ 0.0890 -1359.02%
Jan 03, 2019 David Cast   0.0070 Jan 15, 2019 @ 0.0073 +4.29%
Nov 26, 2018 Kathy Bagnell   0.0146 Dec 26, 2018 @ 0.0890 -509.59%
Nov 23, 2018 Mike Payne   0.0147 Dec 23, 2018 @ 0.0890 +505.44%
Nov 06, 2018 Jeg Arul   0.0135 Dec 06, 2018 @ 0.0890 +559.26%
Nov 05, 2018 Greg Cobb   0.0131 Dec 05, 2018 @ 0.0890 +579.39%
Oct 26, 2018 Kathy Bagnell   0.0160 Nov 25, 2018 @ 0.0890 +456.25%
Oct 19, 2018 Lawrence Hart   0.0198 Nov 18, 2018 @ 0.0890 +349.49%
Oct 17, 2018 christopher Manacapel   0.0138 Nov 16, 2018 @ 0.0890 +544.93%
Oct 17, 2018 Jonathan Medina   0.0135 Nov 16, 2018 @ 0.0890 +559.26%
Oct 05, 2018 Thierry Jacobsoone   0.0370 Nov 04, 2018 @ 0.0890 +140.54%
Oct 02, 2018 Martin Rd   0.0261 Nov 01, 2018 @ 0.0890 +241.00%
Oct 02, 2018 Melissa Stephenson   0.0290 Nov 01, 2018 @ 0.0890 +206.90%
Sep 27, 2018 Graeme Thicke   0.0177 Oct 27, 2018 @ 0.0890 +402.82%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RDGL Comments

Write your thoughts about Vivos Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jason Dessiaume
Jason Dessiaume May 01, 2024 8:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any body know why this hunk of junk is performing
Kathy Bagnell
Kathy Bagnell Mar 31, 2023 9:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
my bank sold the stock on me hmmm I wonder why total set up
Willie Scott
Willie Scott Jun 29, 2022 1:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Have there been any other reports from the FDA???
Kathy Bagnell
Kathy Bagnell Jun 29, 2022 1:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
There was news today you should check it out
Richard Anderson
Richard Anderson Jun 03, 2021 8:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Starting the run up to FDA IDE.  Boston Scientific's TheraSpheres product which is different but same radionuclide was used under IDE for almost 20 years.   A lot of money can be made in this space without having full FDA approval.  FDA IDE is the big step to start using in humans.  I expect a run back up to at least $0.36 leading up to FDA IDE.
Brandon Kent
Brandon Kent May 17, 2021 7:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sorry about the multiple posts, they weren't showing up so I submitted a few times haha.
Brandon Kent
Brandon Kent May 17, 2021 7:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Currently holding 100k shares, the science behind this medical technology is sound (from a nuclear science standpoint), and I personally feel that the success of the pet version (Isopet) leads to a much more likely outcome that it will be a successful human treatment for cancerous, nonresectable (inoperable) tumors.
Brandon Kent
Brandon Kent May 17, 2021 7:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Currently holding 100k shares, the science behind this medical technology is sound (from a nuclear science standpoint), and I personally feel that the success of the pet version (Isopet) leads to a much more likely outcome that it will be a successful human treatment for cancerous, nonresectable (inoperable) tumors.
Brandon Kent
Brandon Kent May 17, 2021 7:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Currently holding 100k shares, the science behind this medical technology is sound (from a nuclear science standpoint), and I personally feel that the success of the pet version (Isopet) leads to a much more likely outcome that it will be a successful human treatment for cancerous, nonresectable (inoperable) tumors.
Giuseppe Giannachi
Giuseppe Giannachi Feb 09, 2021 4:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hi! I would love to join in, but the company is so small that it's hard to gather news, info, data. Anyone? Thanks. Cheers!
G S qr
G S qr Feb 09, 2021 4:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why don't you research the company online.  Tones of info.  Then decide.  Or stick with what you know.
Lisa Watkins
Lisa Watkins Feb 08, 2021 6:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bought 14000
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email